| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |